@article {Garcia-Bournissen229, author = {Facundo Garcia-Bournissen and Alon Shrim and Gideon Koren}, title = {Exposure to sibutramine during pregnancy}, volume = {53}, number = {2}, pages = {229--230}, year = {2007}, publisher = {The College of Family Physicians of Canada}, abstract = {QUESTION One of my patients who was taking sibutramine to lose weight found out that she had unexpectedly conceived. The medication was stopped as soon as she found out, about 5 weeks into the pregnancy. Is the baby at risk? Should the pregnancy be aborted? ANSWER No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations. Nevertheless, this medicationshould be avoided whenever possible during pregnancy, as there is little information on its effects.}, issn = {0008-350X}, URL = {https://www.cfp.ca/content/53/2/229}, eprint = {https://www.cfp.ca/content/53/2/229.full.pdf}, journal = {Canadian Family Physician} }